Dr. Steven Finkelstein stands as a distinguished, board-certified radiation oncologist (DABR, FACRO) celebrated for his pioneering work in advanced cancer treatments and patient-centered care. A cum laude graduate of the University of Michigan Medical School in 1997, Doctor Finkelstein has committed his career to the forefront of cancer care, integrating innovative research with dedicated clinical practice.
Following his medical degree, Doctor Finkelstein furthered his specialization at the National Cancer Institute (NCI) within the NIH. By 2004, he completed rigorous fellowships in Surgical Oncology and Clinical Immunotherapy, establishing a robust foundation in cancer treatment methodologies. His pursuit of expertise led him to radiation oncology, where he achieved the role of Chief Resident at Moffitt Cancer Center/University of South Florida, a testament to his leadership and clinical acumen. Dr. Finkelstein’s career trajectory includes significant leadership positions, such as National Director and Chief Science Officer at the 21C Translational Research Consortium, highlighting his influence in translational research. Driven by a dedication to direct patient impact, Dr. Finkelstein returned to Florida, taking on the role of Cancer Director at Bay Regional Cancer Center before joining Florida Cancer Affiliates, a part of the esteemed US Oncology Network.
Doctor Finkelstein’s clinical interests are broad, encompassing a wide array of cancers, with a focus on radiation-driven and personalized systemic therapies. His commitment to innovation is underscored by his holding three international patents for cutting-edge medical technologies. A prolific scholar and speaker, Doctor Finkelstein has presented at numerous national and international conferences, contributed extensively to peer-reviewed journals and authored book chapters. His scholarly work has garnered over 11,000 citations, reflecting his significant impact on the field, evidenced by an H-Index of 42.
His recognized specialties include cancers of the bladder, kidney, testicles, lung, breast, and skin, showcasing his comprehensive expertise in oncology. Beyond his clinical and research endeavors, Doctor Finkelstein actively shapes the medical community, serving on the editorial boards of leading international journals and as the Associate Editor for Immunotherapy at the American Society of Clinical Oncology (ASCO).
In recognition of his profound contributions to patient care and the field of radiation oncology, Doctor Finkelstein was honored with accelerated fellowship in the American College of Radiation Oncology (ACRO) and was elected to its Board of Chancellors and Chair of Education. For five consecutive years, Doctor Finkelstein has been consistently named a Castle Connolly Top Doctor, affirming his status as a preeminent figure in radiation oncology and a trusted name in cancer care.
